References
Elia J. Drug treatment for hyperactive children: therapeutic guidelines. Drugs 1993; 46: 863–71
Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
Biedermann J. Attention deficit hyperactivity disorder (ADHD). Ann Clin Psychiatry 1991; 3: 9–22
Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35(4): 409–32
Barkley RA. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guilford Press, 1990
Evans SW, Pelham WE. Psychostimulant effects on academic and behavioral measures for ADHD junior high school students in a lecture format classroom. J Abnorm Child Psychol 1991; 19: 537–52
Swanson JM, Cantwell DP, Lerner M, et al. Effects of stimulant medication on learning in children with ADHD. J Learn Disabil 1991; 4: 219–30, 255
Rappley MD. Safety issues in the use of methylphenidate. Drug Saf 1997 Sep; 17(3): 143–8
ABPI Compendium of data sheets and summaries of product characteristics 1998–99. London: Datapharm Publications Ltd., 1998
Gadow KD, Sverd J, Sprafkin J, et al. Efficacy of methylphenidate for attention deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 1995; 52: 444–55
Castellanos FX, Giedd JN, Elia J, et al. Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997; 36(5): 589–96
Jacobvitz D, Sroufe LA, Stewart M, et al. Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry 1990; 29: 677–88
Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996; 98(6): 1084–8
Drug Enforcement Administration. ARCOS (Automation of Reports and Consolidated Orders Systems) Data Base 1981–1994. Washington, DC: US Department of Justice, 1996
Rappely MD, Gardiner JC, Jetton JR, et al. The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med 1995; 149: 675–9
Shaywitz SE, Shaywitz BA. Increased medication use in attention deficit hyperactivity disorder: regressive or appropriate? JAMA 1988; 260(15): 2270–2
Johnson ISR, O’Malley P, Bechman J. National survey results on drug use for monitoring the future study, 1975–1994: vol. 1. Secondary school students. Washington, DC: National Institute of Health, 1995: Rep. no. 95-4026
Carter HS, Watson WA. IV pentazocine/methylphenidate abuse: the clinical toxicity of another Ts and blues competition. J Toxicol Clin Toxicol 1994; 32(5): 541–7
Masand PS, Tesar GE. Use of stimulants in the medically ill. Psychiatr Clin North Am 1996; 19(3): 515–47
Wilens TE, Spencer T, Biederman J, et al. Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 1995; 34(1): 110–2
Rights and permissions
About this article
Cite this article
Methylphenidate effective in children with ADHD but take care. Drugs Ther. Perspect 11, 10–13 (1998). https://doi.org/10.2165/00042310-199811080-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199811080-00005